Skip to main content

Advertisement

Contact Bart JF van den Bemt

From: Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

Contact corresponding author